Search

everythinglearnresearchcommunity

for

Search:↓

Quick, selective detection of tadalafil and finasteride in human plasma developed.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Larger prostate size, longer surgery, and smoking increase risks, while finasteride and experienced surgeons reduce them during prostate surgery.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

Chitosan-decorated nanoparticles can improve skin delivery and reduce side effects of finasteride.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Older age and prostatic hyperplasia in males increase the risk of hemorrhagic cystitis after stem cell transplantation.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Hair loss gene linked to prostate issues.

Physical activity, height, and smoking affect prostate cancer risk.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

A new compound was effective for imaging prostate cancer in rats.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

No link found between hair loss severity and PSA levels in men.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Finasteride and dutasteride reduce prostate cancer risk, but finasteride may increase higher-grade cancer risk.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Early hair loss links to metabolic issues in young Indian men.